Inventor · disambiguated record
Darren L. Bates
Also filed as: BATES DARREN · BATES DARREN L
10 granted patents·6 pending applications·30 citations·filing 2009–2025
85Inventor score
Top patents by PatentIndex Score
16 records- 0191US11541103B2Interleukin-21 mutein/ anti-PD-1 antibody conjugatesAMGEN INC·Filed 2018·Granted Jan 3, 2023·7 cites·34 claims
- 0291US10294303B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2016·Granted May 21, 2019·12 cites·14 claims
- 0386US12252540B2Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Mar 18, 2025·1 cites·5 claims
- 0486US11046774B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2019·Granted Jun 29, 2021·5 cites·18 claims
- 0577US9738696B2Superkines and synthekines: repurposed cytokines with new and enhanced signaling activitiesUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Aug 22, 2017·4 cites·14 claims
- 0671US2025376529A1Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 0768US2023381276A1Interleukin-21 mutein/ anti-pd-1 antibody conjugatesAMGEN INC·Filed 2022·Application pending·0 cites
- 0866US12258411B2Anti-CCR8 antibodies and uses thereofAMGEN INC·Filed 2022·Granted Mar 25, 2025·0 cites·29 claims
- 0965US12187771B2Method of producing Th9 T-cellsUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Jan 7, 2025·0 cites·7 claims
- 1060US8895093B2Method for the production of jelly confectioneryKRNIC PETER·Filed 2009·Granted Nov 25, 2014·1 cites·18 claims
- 1159US12435149B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2018·Granted Oct 7, 2025·0 cites·49 claims
- 1258US10738096B2Superkines and synthekines: repurposed cytokines with new and enhanced signaling activitiesUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Aug 11, 2020·0 cites·11 claims
- 1355US2022402985A1ENGINEERED NRG-1 VARIANTS WITH IMPROVED SELECTIVITY TOWARD ErbB4 BUT NOT AGAINST ErbB3AMGEN INC·Filed 2022·Application pending·0 cites
- 1453US2025171549A1Anti-ccr8 antibodies and uses thereofAMGEN INC·Filed 2025·Application pending·0 cites
- 1553US2024002545A1Novel linkers of multispecific antigen binding domainsAMGEN INC·Filed 2021·Application pending·0 cites
- 1653US2025129160A1T cell engager molecules and uses thereofAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Darren L. Bates files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →